Golimumab Trough Levels in Patients With Ulcerative Colitis

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Ulcerative Colitis
Interventions
DIAGNOSTIC_TEST

Golimumab trough levels

Golimumab trough levels taken immediately before the administration of the next subcutaneous dose of golimumab

DIAGNOSTIC_TEST

Antibodies to golimumab

Antibodies to golimumab taken immediately before the administration of the next subcutaneous dose of golimumab

DIAGNOSTIC_TEST

Histology

Histology of colonic biopsies using the Geboes Index

DIAGNOSTIC_TEST

Colonoscopy

Colonoscopy to evaluate the endoscopic activity by a Mayo endoscopic subscore

Trial Locations (12)

28007

Hospital Gregorio Marañón, Madrid

28034

Hospital Universitario Ramon y Cajal, Madrid

28040

Hospital Clinico San Carlos, Madrid

28041

Hospital 12 de Octubre, Madrid

28046

Hospital Universitario La Paz, Madrid

28222

Hospital Puerta de Hierro, Majadahonda

28703

Hospital Infanta Sofia, San Sebastián de los Reyes

28922

Hospital Universitario Fundación Alcorcón, Alcorcón

28942

Hospital Universitario Fuenlabrada, Fuenlabrada

31008

Complejo Hospitalario de Navarra, Pamplona

46010

Hospital Clínico Universitario de Valencia, Valencia

46026

Hospital Universitario La Fe, Valencia

All Listed Sponsors
collaborator

Hospital Universitario La Fe

OTHER

collaborator

Hospital Universitario 12 de Octubre

OTHER

collaborator

Hospital Universitario Ramon y Cajal

OTHER

collaborator

Gregorio Marañón Hospital

OTHER

collaborator

Complejo Hospitalario de Navarra

OTHER

collaborator

Hospital Universitario Fundación Alcorcón

OTHER

collaborator

Hospital Infanta Sofia

OTHER

collaborator

Hospital Clínico Universitario de Valencia

OTHER

collaborator

Puerta de Hierro University Hospital

OTHER

collaborator

Hospital Universitario La Paz

OTHER

collaborator

Hospital Universitario de Fuenlabrada

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Hospital San Carlos, Madrid

OTHER

NCT03773445 - Golimumab Trough Levels in Patients With Ulcerative Colitis | Biotech Hunter | Biotech Hunter